-
Chronic Lymphocytic Leukemia (CLL) Read more: http://bit.ly/2tjpbWW
#CLL#ChronicLymphocyticLeukemia#ASH2019 pic.twitter.com/6wfCTJ064y
-
EMJ Hematology US Edition is the newest addition to our
#haematology collection, and contains a review of the 61st American Society of#Hematology (ASH) Annual Meeting and Exposition. Be sure to read it today: https://bit.ly/37LCT3N#ASH2019 pic.twitter.com/zqoqUrGRgZ
-
The future of treating chronic lymphocytic leukemia looks pretty promising. Report from CLL at ASH.
@MedscapeOnc@Medscape#ASH2019#leukemiahttps://www.medscape.com/recap/921620?cp_available=true&src=inve … -
Get expert analysis of the biggest news to come out of
#ASH2019. Find out more in our report extract here http://bit.ly/2t6vbSS pic.twitter.com/5y0S6yjAfH
-
Our research team have been at the
#ASH2019 highlights learning about some of the exciting research happening right now. Check out the thread below
(Warning: may contain cat gifs
) https://twitter.com/Bloodwise_res/status/1222129704729182213 …
-
#News: Watch as our@Bryantific talks about his presentation from#ASH2019 w/@gohealio re the use of synthetic control arms in#clinicaltrials + the success his team had in replicating a control group using a synthetic approach in multiple myeloma study: http://bit.ly/2Q2Ch23 pic.twitter.com/ejmCvc8tUd
-
With over 30,000 delegates in attendance, this bustling congress was packed full of ground-breaking research and discussion of the most pressing topics in
#haematology. Be sure to check out the full congress review here: https://bit.ly/2O2Pms4#ASH2019#ASHCongresspic.twitter.com/vIxJJtGDtb -
So true. This junk takes up way too much time. Recently I had to submit justification why my trainees had to attend the
#ASH2019 conference so they could get reimbursed. Takes away valuable time that could be used for actual science https://twitter.com/mammals_suck/status/1221817103537229826 …
-
Our January Issue of Evidence-Based Oncology provides a special recap of key results presented at December’s meeting of the American Society of Hematology in Orlando, Florida. Read the full issue!
#ASH2019 https://bit.ly/30Z1D69 pic.twitter.com/JYfKlh3fSP
-
Upcoming webinar with
#CLL expert@v_banerji "Practice-Changing Studies in Treatment-Naive CLL -- Updates from#ASH2019" Feb 5th from 11am-1pm EST. Register with@ImpactMedicom by Jan 31stpic.twitter.com/QvScv20KWh
-
So after
#ASH2019 I made an appointment with the optometrist only to realize my vision is perfect. You all need to increase your slides’ font size and axis labels!

-
العلاج الجيني لمرضى
#الأنيميا_المنجلية يحرز تقدما كبيرا، دراسة تستهدف الجين المتحكم في الهيموجلوبين الجنيني HbF الذي يسمى BCL11A حيث يتم تعطيل هذا الجين لإعادة تنشيط الهيموجلوبين الجنيني HbF والذي سيؤدي لارتفاع الهيموجلوبين وتخفيف الأعراض المصاحبة للمرض.#ASH2019 pic.twitter.com/ECIIoYvTQS
-
A wonderful speech from Emmanuelle Passegue, winner of the William Dameshek Prize
#ASH2019. Also shown celebrating last night with another of our Haematology#WomeninSTEMM superstars, @TrowbridgeLab (who has also had a very successful ASH!). Proud to call these 2 friends!pic.twitter.com/QZ0xZzxdAE
-
It is rare to witness true practice changing presentations at ASH- oral Azacitidine improves OS and RFS in older AML pts in CR/CRi after intensive induction and consolidation. Favorable-risk was excluded however. Congratulations Andrew Wei & investigators!
#ASH2019#leusmpic.twitter.com/lPGi9QMh8E
-
For those at
#ASH2019, here's a recent article about the great target that BCMA seems to be: https://go.nature.com/38qVTpe#ASH19pic.twitter.com/5BTcwsC5GH
-
Also, don't forget to check out the
@symplur statistics for#ASH19. I made the top 10 most prolific tweeters list!#ASH2019 cc@ASH_hematology@VincentRK@ninashah33@BldCancerDoc@feldstej@hemedoc@DrRaulCordoba@DrAlexisTalbot@pembeoltulu@mabeky@mtmdphd@doctorpemmpic.twitter.com/NQb5rd7DGP
-
Proud to present Venetoclax, Dara and Dex data @
#ASH2019 in t(11;14) MM, 96% VGPR or better. Precision medicine @ it’s best! pic.twitter.com/Wx8asGJbwp
-
Cool study demonstrates that patients with discordant aPTT and heparin anti-Xa levels tend to have poorer outcomes with increased mortality risk Hard to know if this is because discordance is marker of illness or if leads to mgmt decisions that influence outcomes
#ASH2019 pic.twitter.com/RJ1dOAWmSz
-
Erythroferrone is a new hormone that is involved in Iron Deficiency Anemia. It is encoded by ERFE Gene by Erythroblasts in the bone marrow and inhibits Hepcidin in response to ID. Inhibition of Hepcidin leads to more Iron Absorption and more Hemoglobin synthesis.
#ASH2019 pic.twitter.com/KDMBC5q3aF
Prikaži ovu nit -
Kira Young from our lab giving a fantastic presentation on the aging bone marrow microenvironment and IGF1. Our final presentation at
#ASH2019 and I could not be prouder of my trainees. We will take home new ideas, collaborations and inspiration to keep pushing forward! pic.twitter.com/zZxBz210Hm
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.